Biosenta Highlights Independent University of Calgary Research Validating Tri-Filler(TM) Antimicrobial Technology
Toronto, Ontario and Calgary, Alberta--(Newsfile Corp. - July 21, 2026) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today highlighted new research released by the University of Calgary demonstrating the performance of the Company's antimicrobial nanotechnology, Tri-Filler™, being developed in collaboration with researchers at the University of Calgary and the Alberta Centre for Advanced Diagnostics (ACAD).According to the University of Calgary, laboratory testing showed Tri-Filler achieved more than...
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


